The changing statutory and regulatory landscape demands a strategy to avoid the pitfalls.
The medical device industry is one of the most heavily regulated, and when
paired with unparalleled innovation in the device and digital health spaces more
broadly, the risks for companies involved in the development, manufacture,
importation, and distribution are only rising. It is crucial that medical device and
digital health companies understand their legal and regulatory responsibilities.
We work with our clients as partners and trusted advisors to
translate legal and regulatory requirements into operational
excellence to achieve and maintain compliance.
Here are some of the ways we can help:
Developing and managing premarket regulatory strategies (e.g., IDE, Q-Sub, 513(g), 510(k), De Novo request, PMA, CE, UKCA) for commercialization in the U.S., EU, and other international markets. This includes building submission packages, planning and incorporating clinical studies, and interacting with regulators throughout the submission review process.
Advising executive, quality and regulatory teams on global regulatory requirements and assisting in the establishment and/or remediation of Quality Management Systems (QMSs).
Drafting and negotiating device-specific contracts (e.g., purchase order agreements, supplier quality agreements, research agreements)
Advising executive teams on optimal organizational structures and staffing levels for quality, regulatory, and supporting functions.
Preparing organizations for regulatory inspections/audits, providing real-time management of active inspections/audits, managing inspection/audit responses, and developing corrective action plans.
Drafting responses, remediation plans, and periodic updates to regulators in cases of Form 483 inspection observations, notified body audit findings, Warning Letters, and injunction.
Operationalizing regulatory frameworks for AI/ML-enabled medical devices into product submissions and the QMS.
Incorporating cybersecurity requirements into product submissions and the QMS. In partnership with our sister company, Brooke Biomedical, we also provide SBOM creation, threat modeling, penetration testing, and static and dynamic code analysis from world class cybersecurity experts that bring both government and commercial experience to bear on your product ecosystem.
Leading regulatory evaluations for mergers & acquisitions, ensuring compliance risk assessments are integrated into transactional decisions.
Serving as an expert witness in FDA compliance-related litigation.
Evaluating promotional materials for legal and regulatory compliance.
Serving as U.S. agent to the FDA on behalf of foreign manufacturers.